HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Guangfeng Wang Selected Research
Guangfeng Wang Research Topics
Disease
13
Neoplasms (Cancer)
01/2024 - 12/2013
2
Leukemia
01/2022 - 02/2019
1
B-Cell Lymphoma (Lymphoma, B Cell)
12/2022
1
Waldenstrom Macroglobulinemia (Macroglobulinemia)
12/2022
1
Multiple Myeloma
12/2022
1
B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
12/2022
1
Hematologic Neoplasms (Hematological Malignancy)
12/2022
1
Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2022
1
Hepatocellular Carcinoma (Hepatoma)
01/2021
1
Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
09/2020
1
Carcinogenesis
06/2019
1
Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor)
01/2019
1
BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
01/2019
1
Pathologic Processes
02/2015
Drug/Important Bio-Agent (IBA)
3
Lisaftoclax
IBA
12/2022 - 09/2020
2
Proteins (Proteins, Gene)
FDA Link
12/2022 - 09/2017
2
olverembatinib
IBA
01/2022 - 01/2019
2
DNA (Deoxyribonucleic Acid)
IBA
01/2021 - 02/2019
2
MicroRNAs (MicroRNA)
IBA
01/2021 - 06/2019
2
Becaplermin (PDGF-BB)
FDA Link
09/2017 - 01/2015
2
Folic Acid (Vitamin M)
FDA Link
Generic
07/2015 - 02/2015
1
Messenger RNA (mRNA)
IBA
01/2024
1
Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)
IBA
12/2022
1
Caspases
IBA
12/2022
1
Paclitaxel (Taxol)
FDA Link
Generic
07/2022
1
osimertinib
IBA
07/2022
1
Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)
IBA
07/2022
1
Tyrosine Kinase Inhibitors
IBA
07/2022
1
Aldehyde Dehydrogenase
IBA
07/2022
1
Drug Combinations
IBA
07/2022
1
Mitogens
IBA
07/2022
1
Carboplatin (JM8)
FDA Link
Generic
07/2022
1
Mitogen-Activated Protein Kinase Kinases (MEKs)
IBA
07/2022
1
ErbB Receptors (EGF Receptor)
IBA
07/2022
1
Tetrazolium Salts
IBA
07/2022
1
trametinib
IBA
07/2022
1
STAT5 Transcription Factor
IBA
01/2022
1
Biomarkers (Surrogate Marker)
IBA
01/2021
1
Imatinib Mesylate (Gleevec)
FDA Link
01/2019
1
ponatinib
IBA
01/2019
1
Phosphotransferases (Kinase)
IBA
01/2019
1
Silver
IBA
07/2015
1
Indicators and Reagents (Reagents)
IBA
01/2015
1
Antineoplastic Agents (Antineoplastics)
IBA
12/2013
1
Cisplatin (Platino)
FDA Link
Generic
12/2013
Therapy/Procedure
3
Therapeutics
07/2022 - 02/2015
1
Precision Medicine
06/2022
1
Photothermal Therapy
06/2022